Study shows specific type of herpes could cause breast cancer

No one wants to contract herpes, but it may even be more of a concern for women, according to new research that found it could put some women at increased risk for getting breast cancer.

The study, published in the July issue EBioMedicine, found that the Epstein-Barr virus (EBV), the most common of the eight known viruses in the herpes family, could contribute to a woman getting developing breast cancer.

EBV is best known as the cause of infectious mononucleosis, otherwise known as mono. More than 90 percent of people globally carry EBV, though most never experience symptoms. It has been linked to illnesses such cancer and Hodgkin’s disease, but it is still difficult to identify what diseases it triggers.

A team of scientists led by Gerburg Wulf, MD, PhD, a physician in the hematology/oncology division at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, studied primary mammary epithelial cells found in the breast and examined their reactions in the presence of EBV.

Testing their theory on mice, they implanted primary mammary epithelial cells and the EBV and found that the virus cooperated with certain cancer-causing proteins that accelerated the formation of breast cancer. The infected mammary cells had genetic characteristics associated with an aggressive breast cancer receptor.

The virus binds to the CD21 receptor in normal breast cells, which eventually leads to infection. The infection causes the cells to take on characteristic of stem cells, which allows them to continue dividing.

EBV has also been linked to breast cancer in other studies around the world in India, China, Africa and southern Europe.

Though Wulf’s study cannot necessarily prove EBV causes breast cancer, the research does indicate that it contributes to the development of it, making the case for the creation of an EBV vaccine.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.